CALA
Assenagon Asset Management’s Calithera Biosciences, Inc CALA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-753,682
| Closed | -$304K | – | 1586 |
|
|
2022
Q1 | $304K | Hold |
753,682
| – | – | ﹤0.01% | 1242 |
|
|
2021
Q4 | $501K | Sell |
753,682
-96
| -0% | -$64 | ﹤0.01% | 1151 |
|
|
2021
Q3 | $1.64M | Buy |
753,778
+402,972
| +115% | +$878K | 0.01% | 723 |
|
|
2021
Q2 | $733K | Buy |
+350,806
| New | +$733K | ﹤0.01% | 925 |
|
|
2020
Q4 | – | Sell |
-199,905
| Closed | -$690K | – | 1278 |
|
|
2020
Q3 | $690K | Sell |
199,905
-93,775
| -32% | -$324K | ﹤0.01% | 887 |
|
|
2020
Q2 | $1.55M | Buy |
+293,680
| New | +$1.55M | 0.01% | 650 |
|
|
2019
Q4 | – | Sell |
-10,428
| Closed | -$32K | – | 958 |
|
|
2019
Q3 | $32K | Sell |
10,428
-151,972
| -94% | -$466K | ﹤0.01% | 765 |
|
|
2019
Q2 | $633K | Buy |
+162,400
| New | +$633K | ﹤0.01% | 770 |
|